Sigma shares fall as takeover talks swirl
Investor attention centres on Sigma Healthcare after the Chemist Warehouse owner emerges as a potential bidder for UK chain Boots, a deal that would reshape its footprint. Shares on the ASX rise overall, supported by consumer names, but Sigma drops about 5% as the market digests the execution risk tied to a cross-border acquisition.
Trading in insurance broker Steadfast is halted after it receives a takeover proposal, adding another live corporate deal to the session’s drama.
Deal speculation and sector moves drive volatility
Boots is a major UK pharmacy and retail health chain, so any Sigma approach would represent a significant offshore expansion for the Chemist Warehouse owner. Investors weigh funding needs, integration complexity and regulatory approvals, which could pressure Sigma’s balance sheet and earnings if the deal proceeds.
The broader consumer sector benefits from buying interest, helping lift the ASX even as Sigma lags. Steadfast’s trading halt shows that corporate activity remains a powerful catalyst for sudden price swings across the market.
US strikes Iran, says response now complete
The United States says its retaliatory strikes on Iranian targets are now complete after a US helicopter was downed, escalating tensions in the region. Washington insists a negotiated outcome is still possible, keeping diplomatic channels open even as it demonstrates military resolve.
Iran responds by signalling it will not leave any attack unanswered and reportedly targets Bahrain, alarming regional observers.
